27
Jul
Dinesh Lodha, Managing Director & Group CEO, Medikabazaar New Delhi [India], July 27: Medikabazaar, India’s leading B2B healthcare supply chain platform, has reported a robust start to FY 2026–27, delivering an impressive 57% year-on-year growth in Q1, reinforcing its position as one of India’s fastest-growing healthcare commerce and technology companies. Building on the strong momentum of FY 2025–26, the company is firmly on track to achieve a ₹3,000 crore topline in FY 2026–27, representing approximately 45% growth over the previous financial year, while targeting a 15-fold increase in EBITDA. The performance reflects Medikabazaar’s disciplined approach to profitable growth, operational excellence,…
